Innovation in Medicine

A machine learning framework to predict and quantify synthesis difficulties for designer chromosomes


Artificially synthesizing genomes has broad prospects in fields such as medical research and developing industrial strains. From the synthesis of the artificial life JCVI-syn1.0 by Craig Venter’s team in 2010, to the rewriting and synthesis of the prokaryotic E. coli genome, and to the Sc2.0 project’s artificial synthesis of the yeast genome, researchers are constantly advancing in the depth and breadth of genome design and synthesis.

Forward genetic screening reveals important pathways for sleep regulation in C. elegans

Previous article

Study paves way to more efficient production of 2G ethanol using specially modified yeast strain

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *